Developmental hemostasis: pro- and anticoagulant systems during childhood.
about
Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies.Neonatal brain hemorrhage (NBH) of prematurity: translational mechanisms of the vascular-neural networkNeonatal platelets: mediators of primary hemostasis in the developing hemostatic systemThe host response to sepsis and developmental impactSuccessful mechanical thrombectomy in a 2-year-old male through a 4-French guide catheter.The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgeryCurrent use of factor concentrates in pediatric cardiac anesthesia.Animal models of germinal matrix hemorrhage.Massive Transfusion of 5 U Packed Redblood Cells, 3 U Fresh Frozen Plasma, and 160 cc of Platelets in a 14-Month-Old PatientFibrin Network Changes in Neonates after Cardiopulmonary Bypass.Pediatric Sepsis - Part I: "Children are not small adults!"Enoxaparin use in the neonatal intensive care unit: experience over 8 years.Population pharmacokinetics of epsilon-aminocaproic acid in infants undergoing craniofacial reconstruction surgeryThromboembolism in infants and children with gastrointestinal failure receiving long-term parenteral nutrition.Vascular catheter-related complications in newborns.The use of anti-Xa assay to monitor intravenous unfractionated heparin therapy.Retrospective evaluation of enoxaparin dosing in patients 48 weeks' postmenstrual age or younger in a neonatal intensive care unit.Massive transfusion in children and neonates.Coagulation and the surgical neonate.Thromboelastography in term neonates.Risk Factors, Prophylaxis, and Treatment of Venous Thromboembolism in Congenital Heart Disease PatientsSuccessful treatment with Protein C of febrile neutropenia in pediatric patients during cancer therapy.Alterations in the Coagulation System during Major Visceral Surgery in Children.Protein S modulates the anticoagulant action of recombinant human activated protein C: a comparison between neonates and adults.Perioperative course of FXIII in children undergoing major surgery.The effect of labour on the coagulation system in the term neonate.Evaluation of the use of low-molecular-weight heparin in neonates: a retrospective, single-center study.Advances in predicting venous thromboembolism risk in children.Effects of albumin 5% and artificial colloids on clot formation in small infants.Phase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability.Significant associations among hemostatic parameters, adipokines, and components of the metabolic syndrome in Japanese preschool children.Age-associated developmental changes in the activated partial thromboplastin time (APTT) and causes of prolonged APTT values in healthy Chinese children.Anticoagulant Effects of Dabigatran in Paediatric Patients Compared with Adults: Combined Data from Three Paediatric Clinical Trials
P2860
Q24810495-26F6D6BA-4B70-4EC4-AC2C-31C9791AE8B3Q26827381-9D4882D2-7522-453F-BF10-2D17B2F5DB30Q26852908-69CA6AA9-E1B0-4620-9ED5-AA55C2CA20DBQ33950741-CA7769A8-9779-462B-84BC-048127654951Q34551635-1CF54FF0-6738-4A60-A474-98E7ADCF5DE0Q35587102-A34C300E-ED74-40F3-B56A-F1D3F444265CQ36341729-555C3DCF-30FB-4A91-A996-59C679B99328Q36562293-100F7A3D-D8FD-48CD-9682-FD58FFC3E0CDQ36776562-920FACE2-59D6-4B5D-97A9-1A90CEF23CAFQ36813676-7BFD006F-0F42-4EE3-AD50-B9FA548CD189Q36880764-50AE2338-DD1C-48A7-9FD0-EC9087A2FF1AQ36920696-122C7557-EDE8-4E49-806A-7ACA19DCDD32Q36963877-C154CE04-E303-4B81-B685-DC01872CC2A1Q37047560-0B21C0B5-5246-425D-B9AD-88AC46B95F70Q37825566-1ED28BD4-9A35-4B9A-BD3B-DACA817B3421Q37867278-CCFB31C4-B4E0-4F98-998B-F125ED8B1383Q38029256-852F0B83-C118-4C3E-B1C8-0F6EF146ABD7Q38083755-55248735-C79F-4616-ACFC-D4601B352DFCQ38163073-9C11DB71-964E-4E1C-9B31-615FD1CEBA7DQ38702019-4236741D-2AA3-49D8-A35B-9751373BD25EQ39412895-6D574175-8C28-4348-AEAA-28752E1491A4Q40396604-3F18DD14-7B7A-466D-8E0C-B9C98028E347Q42085220-F5041C1C-E07E-4667-B188-0E4AAFA23E1CQ43054818-77CE36BA-2D8C-4885-9DDE-FE2676FC56F6Q44868346-C7ED6BE6-624E-47FE-B4E2-4E61829A05A7Q45886369-82CBC9DB-DAE0-407D-921B-3238CD50EFACQ45904775-C38CF978-E7F2-41FE-9158-0E133E18459EQ48371897-512CA882-4792-469A-9029-D00B36B1DE5EQ48565462-B8473DE0-3985-4115-B0F8-04ECF5ECB3FBQ50044683-47E0A877-3787-41FE-A5CA-EA790D1DEAF5Q51367579-0E11BE79-E0CD-4FC1-8D3B-58CCF99D26CBQ51801537-EF97E9BA-1118-45E4-9A65-7F3B46EFBA68Q58775550-A291AB13-1AEA-48F7-88EC-E4057FA483E9
P2860
Developmental hemostasis: pro- and anticoagulant systems during childhood.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Developmental hemostasis: pro- and anticoagulant systems during childhood.
@ast
Developmental hemostasis: pro- and anticoagulant systems during childhood.
@en
type
label
Developmental hemostasis: pro- and anticoagulant systems during childhood.
@ast
Developmental hemostasis: pro- and anticoagulant systems during childhood.
@en
prefLabel
Developmental hemostasis: pro- and anticoagulant systems during childhood.
@ast
Developmental hemostasis: pro- and anticoagulant systems during childhood.
@en
P2093
P356
P1476
Developmental hemostasis: pro- and anticoagulant systems during childhood.
@en
P2093
Christoph Male
Lesley Mitchell
Stefan Kuhle
P304
P356
10.1055/S-2003-42584
P577
2003-08-01T00:00:00Z